Mr. Jonathan Robinson reports

VENTRIPOINT ANNOUNCES DATE AND WEBINAR DETAILS REGARDING FIRST QUARTER 2023 FINANCIAL RESULTS

Ventripoint Diagnostics Ltd. will release its first quarter, unaudited financial results for 2023 on Tuesday, May 30, 2023, at close of market.

Ventripoint will hold a webinar/conference call at 10 a.m. ET on Thursday, June 1, 2023, to discuss its Q1 2023 financial results and to provide an update on sales and marketing activities of Q1.

Details of the webinar/conference call are as follows:

Participant telephone numbers

Participant site:  C Meeting website

Alternatively, if participant does not have Internet, please call:

Canada/United States toll-free:  1-844-763-8274

International toll:  1-647-484-8814

To ensure your participation, please dial in five to 10 minutes prior to the scheduled start time and simply ask to join the call.

About Ventripoint Diagnostics Ltd.

Ventripoint has become an industry leader in the application of AI (artificial intelligence) to echocardiography. Ventripoint's VMS products are powered by its proprietary KBR (knowledge-based reconstruction) technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI (magnetic resonance imaging). This affordable, gold-standard alternative allows cardiologists greater confidence in the management of their patients. Providing better care to patients serves as a springboard and basic standard for all of Ventripoint's products that guide its future developments. In addition, VMS+ is versatile and can be used with all ultrasound systems from any vendor supported by regulatory market approvals in the United States, Europe and Canada.

We seek Safe Harbor.